3 results
The primary objectives of this study are: * To characterize the effects of 150 mg and 450 mg of AT1001 administered 2 hours before administration of agalsidase on the safety and plasma pharmacokinetics of agalsidase in subjects with Fabry Disease*…
The objective of this pilot study is to investigate the efficiency of a glucose monitor device placed in a tear fluid of human eye to measure glucose for up to 6 hours and its correlation to blood glucose values. Additionally, more information will…
The objective of this pilot study is to investigate if glucose measurement on the vaginal wall can be an alternative for capillary and subcutaneous glucose measurement. The present study will look at the efficacy of an intravaginal device to measure…